<prompt> All of the following are true about CRASH-2 trial except:Dose of tranexamic acid is 1 gm IV over 10 minutes followed by 1 gm over 8 hoursGiven to all trauma patients suspected to have significant hemorrhage including SBP 110 mm Hg or PR 110minShould be administered within 3 hours of injuryTranexamic acid reduces the risk of moality from bleeding in blunt trauma but not in penetrating trauma  <response>: CRASH-2 TRIAL Recommends use of Tranexamic acid in hypotensive trauma patients 1 gm IV over 10 minutes followed by 1 gm over 8 hours Advantages- Reduces the risk of moality from bleeding in both blunt penetrating trauma Indications for Tranexamic acid- All trauma patients suspected to have significant hemorrhage including SBP 110 mmHg or PR 110min- Administrated within 3 hours of injury 